EP0614908B1 - Procédé de préparation des dérivés de l'acide 3-bêta-aminocholanique - Google Patents
Procédé de préparation des dérivés de l'acide 3-bêta-aminocholanique Download PDFInfo
- Publication number
- EP0614908B1 EP0614908B1 EP94102994A EP94102994A EP0614908B1 EP 0614908 B1 EP0614908 B1 EP 0614908B1 EP 94102994 A EP94102994 A EP 94102994A EP 94102994 A EP94102994 A EP 94102994A EP 0614908 B1 EP0614908 B1 EP 0614908B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- formula
- phthalimide
- aminocholanic
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 0 C*(C)C(CCC(C(CC[C@]1[C@@]2C(**)C3)[C@@]1(C)[C@@](*)C[C@@]2[C@@](C)(CC1)[C@@]3C[C@@]1O)I)=O Chemical compound C*(C)C(CCC(C(CC[C@]1[C@@]2C(**)C3)[C@@]1(C)[C@@](*)C[C@@]2[C@@](C)(CC1)[C@@]3C[C@@]1O)I)=O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Definitions
- 3 ⁇ -aminocholanoic acid esters are becoming increasingly important as valuable intermediates for the preparation of compounds for a number of pharmaceutical applications.
- You will e.g. B. used as synthesis building blocks for the production of drug-bile acid conjugates (EP-A-0 417 725 U.S. Patent Application No. 07 / 806,799).
- the bile acid residue acts as a carrier in these conjugates and allows liver-selective transport of the covalently bound active substance via the enterohepatic cycle.
- These bile acid derivatives are selective inhibitors of the intestinal bile acid transport system and therefore lead to an interruption of the enterohepatic circulation and thus to a decrease in the plasma cholesterol level.
- the corresponding oxime is thus prepared from 3-ketocholic acids.
- the oxime function can be reduced with sodium / amyl alcohol (Redel et al., Bull. Soc. Chim. Fr. 877, (1949)) or under catalytic conditions with hydrogen (Satoh, Bull. Chem. Soc. Jap., 1965, 38 , 1581).
- the disadvantage of this process is that isomeric mixtures of the 3 ⁇ - and 3 ⁇ -aminocholanoic acid derivatives of the formula I are obtained in all cases and have to be separated and purified in a complex manner.
- the stereoselectivity varies with the substrates and the reaction conditions, furthermore these processes only give moderate yields.
- the reaction is stereochemically clear. Subsequent reduction of the azido group leads to 3-aminocholanoic acid esters. However, carrying out the reaction in the azide exchange is problematic, since in this process azide compounds are exposed to high temperatures (of approx. 130 ° C.) for a long time. Furthermore, the yields are only in the range from 30 to 50%.
- the reaction of compound III with phthalimide is advantageously carried out under the conditions of the Mitsunobu reaction (Mitsunobu, Synthesis 1, 1981; Org. React. Vol. 42, 335 (1992)) in the presence of a suitable phosphine, preferably triphenylphosphine, and azodicarboxylic acid diethyl (or diisopropyl) ester.
- a suitable phosphine preferably triphenylphosphine, and azodicarboxylic acid diethyl (or diisopropyl) ester.
- a suitable solvent such as tetrahydrofuran or dioxane, at from 20 to 50.degree.
- the free compound of formula II is obtained from the salts by customary methods.
- reaction is that no protective groups for hydroxyl groups in positions 7 or 12 are required, the reaction is regioselective and only takes place in the 3-position, furthermore it is diastereoselective, it arises exclusively from the 3 ⁇ -hydroxy group of the steroid the 3 ⁇ -phthalimide derivative in high yields.
- Mineral acids are e.g. B. sulfuric acid, nitric acid and hydrochloric acid.
- An aqueous solution of hydrochloric acid is preferably used in the process according to the invention.
- Esters of the formula III are prepared from the corresponding acids by customary processes.
- 450 ml of acetyl chloride are slowly added dropwise to 4.5 l of methanol with ice cooling, so that the temperature does not exceed 10 to 15 ° C.
- the mixture is stirred for a further 15 minutes at about 10 ° C.
- 600 g (1.47 mol) cholic acid are introduced at about 5 ° C.
- the ice bath is removed and the reaction is complete after a further hour with stirring.
- the reaction mixture is slowly added to 12 l of water.
- the mixture is stirred for a further 2 hours, then suction filtered and washed with 3 l of water.
- the crystalline substance is dried at 50 ° C in a vacuum. 610 g (98%) of methyl cholic acid (mp. 154 ° C.) are obtained.
- a mixture of 500 g (1.18 mol) of methyl cholic acid, 341 g (1.30 mol) of triphenylphosphine and 191 g (1.29 mol) of phthalimide is heated to 40 ° C. in 3.0 l of absolute THF.
- a solution of 400 ml (2.57 mol) of diethyl azodicarboxylate and 200 ml of THF is slowly added dropwise with stirring and under a protective gas, so that the temperature does not exceed 40 to 50 ° C. (slight cooling required). After the addition, the mixture is stirred at about 45 ° C. for a further 1.5 hours.
- the reaction mixture is concentrated *.
- Example 1 200 g (0.36 mol) of Example 1 are dissolved in 1.6 l of methanol, mixed with 60 ml of 80% hydrazine hydrate and heated under reflux for 3 hours. The reaction mixture is cooled to 40 ° C. and 480 ml of 2N hydrochloric acid are added rapidly until a pH of about 2 to 3 is reached. After a further 30 minutes at 40 ° C, the mixture is cooled to -5 ° C and suctioned off from the by-products. The solution obtained is brought to pH 6 to 7 with sodium hydrogen carbonate (approx. 35 g). The mixture is then concentrated until the total volume is approximately 500 ml.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (3)
- Procédé de préparation de dérivés de l'acide 3β-aminocholanique de formule II,R(1) = H, OH,R(2) = H, α-OH ou β-OHetR(3) est un radical alkyle en C1-C4 non ramifié, un radical alkyle ramifié en C3-C4 ou un radical benzyle,et de leurs sels avec des acides minéraux, caractérisés en ce quea) on fait réagir un ester de l'acide 3α-hydroxycholanique de formule IIIb) on fait réagir un ester de l'acide 3β-phtalimido-cholanique de formule IV obtenu avec de l'hydrate d'hydrazine ou de la phénylhydrazine, etc) on clive le groupe phtalimide par traitement du produit de la réaction avec une solution aqueuse d'un acide minéral, réaction dans laquelle se forme un sel d'addition avec un acide du composé II avec l'acide minéral, etd) on transforme éventuellement un sel obtenu en le composé libre.
- Procédé selon la revendication 1, caractérisé en ce que l'on effectue la réaction des composés de formule III avec du phtalimide en présence d'une phosphine et de l'azodicarboxylate de diéthyle ou de diisopropyle.
- Procédé selon la revendication 1, caractérisé en ce qu'on utilise comme acide minéral de l'acide chlorhydrique aqueux.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4307305 | 1993-03-09 | ||
DE4307305 | 1993-03-09 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0614908A2 EP0614908A2 (fr) | 1994-09-14 |
EP0614908A3 EP0614908A3 (en) | 1995-11-15 |
EP0614908B1 true EP0614908B1 (fr) | 1997-05-07 |
Family
ID=6482260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94102994A Expired - Lifetime EP0614908B1 (fr) | 1993-03-09 | 1994-02-28 | Procédé de préparation des dérivés de l'acide 3-bêta-aminocholanique |
Country Status (9)
Country | Link |
---|---|
US (1) | US5486626A (fr) |
EP (1) | EP0614908B1 (fr) |
JP (1) | JP3308094B2 (fr) |
AT (1) | ATE152729T1 (fr) |
CA (1) | CA2118565C (fr) |
DE (1) | DE59402632D1 (fr) |
DK (1) | DK0614908T3 (fr) |
ES (1) | ES2104208T3 (fr) |
GR (1) | GR3023711T3 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6601104B1 (en) * | 1999-03-11 | 2003-07-29 | Realtime Data Llc | System and methods for accelerated data storage and retrieval |
IT1313617B1 (it) * | 1999-08-31 | 2002-09-09 | Bracco Spa | Processo per la preparazione di derivati degli acidi biliari. |
WO2005113008A1 (fr) * | 2004-05-21 | 2005-12-01 | Mediplex Corp. | Delivrance d'agents permettant d'ameliorer l'absorption mucosale d'agents therapeutiques |
CN102766188B (zh) * | 2012-07-24 | 2016-01-13 | 上海交通大学 | 胆固醇衍生物、螯合物、重组高密度脂蛋白及其用途 |
CN106496300B (zh) * | 2016-10-19 | 2018-05-18 | 上海博志研新药物技术有限公司 | 花生胆酸及其中间体的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE144988T1 (de) * | 1990-12-06 | 1996-11-15 | Hoechst Ag | Gallensäurederivate, verfahren zu ihrer herstellung und verwendung dieser verbindung als arzneimittel |
-
1994
- 1994-02-28 DK DK94102994.4T patent/DK0614908T3/da active
- 1994-02-28 DE DE59402632T patent/DE59402632D1/de not_active Expired - Lifetime
- 1994-02-28 AT AT94102994T patent/ATE152729T1/de active
- 1994-02-28 ES ES94102994T patent/ES2104208T3/es not_active Expired - Lifetime
- 1994-02-28 EP EP94102994A patent/EP0614908B1/fr not_active Expired - Lifetime
- 1994-03-07 US US08/206,321 patent/US5486626A/en not_active Expired - Lifetime
- 1994-03-08 CA CA002118565A patent/CA2118565C/fr not_active Expired - Lifetime
- 1994-03-08 JP JP03666894A patent/JP3308094B2/ja not_active Expired - Lifetime
-
1997
- 1997-06-09 GR GR970401352T patent/GR3023711T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5486626A (en) | 1996-01-23 |
DE59402632D1 (de) | 1997-06-12 |
CA2118565C (fr) | 2003-12-02 |
GR3023711T3 (en) | 1997-09-30 |
JPH06321982A (ja) | 1994-11-22 |
ATE152729T1 (de) | 1997-05-15 |
DK0614908T3 (da) | 1997-10-13 |
EP0614908A3 (en) | 1995-11-15 |
ES2104208T3 (es) | 1997-10-01 |
EP0614908A2 (fr) | 1994-09-14 |
CA2118565A1 (fr) | 1994-09-10 |
JP3308094B2 (ja) | 2002-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2526373C2 (de) | Verfahren zur Herstellung von Δ↑9↑↑(↑↑1↑↑1↑↑)↑-5α-20-Ketosteroiden | |
US5565587A (en) | Process for the preparation of taurocholanic acids | |
EP0614908B1 (fr) | Procédé de préparation des dérivés de l'acide 3-bêta-aminocholanique | |
DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
CN114349810A (zh) | 甾类化合物通用的手性拆分方法 | |
EP0042606B1 (fr) | Procédé de préparation d'acides 17-alpha hydroxy et 17a-alpha hydroxy-D-homo étio carboxyliques | |
EP0190322A1 (fr) | Procede de preparation de composes amines a partir de composes hydroxyles. | |
DE2603545C3 (de) | Neue 16 a -Methyl-17 a - brom-prednisolon- und prednisonderivate und Verfahren zu deren Herstellung | |
CN115611961B (zh) | 胆酸中间体a2及其制备方法 | |
CN115651049B (zh) | 胆酸中间体a3及其制备方法 | |
DE69331764T2 (de) | 17-halogen-4-azaandrosten-derivate und verfahren zu ihrer herstellung | |
EP0039861B1 (fr) | Procédé de dégradation du groupe 20-carboxy de delta 1,4-BNC (bis-nor-cholanic acid) et de dérivés stéroides apparentés et nouveaux stéroides azotés à 21 carbones | |
DE19631543C1 (de) | Verfahren zur Herstellung von 3-Sulfatoxy-estra-1,3,5(10)-trien-Derivaten I | |
US2842544A (en) | Ketosteroid dihydroperoxide derivatives, its esters, tetroxanes and methods of making same | |
DE69608134T2 (de) | Verfahren zur herstellung von (11beta,16beta)-21-(3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione | |
EP0041612B1 (fr) | Procédé de préparation de 20-Carbonylsteroides par dégradation d'acides stéroide-22-carboxyliques | |
DE1903118C (de) | Verfahren zur Herstellung von 17 alpha Monoestern von 11 beta, 17 alpha 21-Tnhydroxysteroiden | |
RU2129125C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ 13α--1,3,510-ТРИЕН-19-НОРАНДРОСТАН-3-ОЛ-17-ОНА И ЕГО МЕТИЛОВОГО ЭФИРА | |
US3125587A (en) | Chscoo- | |
DE1593213C3 (de) | Verfahren zur Herstellung von Steroidazinen Ausscheidung aus 1248653 | |
DE10148682B4 (de) | Verfahren zur Herstellung von ω-Aminoalkansäuren und deren Alkalimetallsalzen | |
LU86486A1 (de) | Verfahren zur herstellung von 10 -methoxy-6-methylergolin-derivaten und ihren saeureadditionssalzen | |
EP0005523A1 (fr) | D-Homostéroides, procédé pour leur préparation | |
DE1166190B (de) | Verfahren zur Herstellung von Steroidestern | |
DE2734459A1 (de) | Peruvosid-derivate und verfahren zu ihrer herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE |
|
17P | Request for examination filed |
Effective date: 19960515 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
17Q | First examination report despatched |
Effective date: 19960913 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE |
|
REF | Corresponds to: |
Ref document number: 152729 Country of ref document: AT Date of ref document: 19970515 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 59402632 Country of ref document: DE Date of ref document: 19970612 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: 73797 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19970711 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: FG4A Free format text: 3023711 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2104208 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050228 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20091201 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20120220 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20130212 Year of fee payment: 20 Ref country code: DE Payment date: 20130220 Year of fee payment: 20 Ref country code: IE Payment date: 20130212 Year of fee payment: 20 Ref country code: CH Payment date: 20130212 Year of fee payment: 20 Ref country code: SE Payment date: 20130212 Year of fee payment: 20 Ref country code: GB Payment date: 20130228 Year of fee payment: 20 Ref country code: ES Payment date: 20130218 Year of fee payment: 20 Ref country code: FR Payment date: 20130301 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20130209 Year of fee payment: 20 Ref country code: BE Payment date: 20130212 Year of fee payment: 20 Ref country code: GR Payment date: 20130124 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20130227 Year of fee payment: 20 Ref country code: AT Payment date: 20130110 Year of fee payment: 20 |
|
BE20 | Be: patent expired |
Owner name: *HOECHST A.G. Effective date: 20140228 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 59402632 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EUP Effective date: 20140228 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20140228 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V4 Effective date: 20140228 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20140227 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MK9A |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK07 Ref document number: 152729 Country of ref document: AT Kind code of ref document: T Effective date: 20140228 |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: MA Ref document number: 970401352 Country of ref document: GR Effective date: 20140301 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140301 Ref country code: IE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140228 Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140227 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20140509 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20140301 |